Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-10-08		NCT07355335

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bristol-Myers Squibb	422
Kura Oncology, Inc.	11
Massachusetts General Hospital	758

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana-Farber Cancer Institute	Boston	United States	626
Massachusetts General Hospital	Boston	United States	1015

Clinical trials